Intermedus - Company finances
|
EUR
|
2019
From: 2019-01-02
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 10 | 6,287 | 12,986 | 37,069 | 26,619 | 12,766 | 5,179 |
| Profit before tax | 4 | -128 | 840 | 5,449 | 335 | -4,391 | -838 |
| Net profit | 4 | -128 | 804 | 5,177 | 351 | -4,391 | -838 |
| Equity | 54 | -75 | 729 | 5,906 | 5,494 | 1,103 | -487 |
| Liabilities | - | - | - | 1,308 | 893 | 799 | 457 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 59 | 90 | 2,086 | 7,214 | 6,387 | 1,902 | -30 |
| Total assets | 59 | 90 | 2,086 | 7,214 | 6,387 | 1,902 | -30 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +62770.0% | +106.6% | +185.5% | -28.2% | -52.0% | -59.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.8% | -142.2% | 38.5% | 71.8% | 5.5% | -230.9% | - |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 7.4% | - | 110.3% | 87.7% | 6.4% | -398.1% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 40.0% | -2.0% | 6.2% | 14.0% | 1.3% | -34.4% | -16.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 40.0% | -2.0% | 6.5% | 14.7% | 1.3% | -34.4% | -16.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.2 | 0.2 | 0.7 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Intermedus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-05-15 | 2024-05-20 | 78.12 |
Intermedus - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Intermedus, MB (code 304979570) is a Small partnership operating in other non-specialised retail sale. In financial year 2025, the company generated revenue of €5.2K, down 59.4% year on year and 80.5% below the 2023 level. Profitability remained weak: net profit was -€838 in 2025, after a loss of -€4.4K in 2024 and a small profit of €351 in 2023. The 2025 profit margin was -16.2%, showing continued pressure on operating performance. Over the last three years, the revenue trajectory has moved from €26.6K in 2023 to €12.8K in 2024 and then to €5.2K in 2025, while the business shifted from marginal profitability to consecutive losses. At the end of 2025, total assets were -€30, equity was -€487 and liabilities were €457. The negative equity and very small asset base mean return and leverage ratios are heavily distorted and should be interpreted cautiously. Overall, the latest year shows a materially weaker financial position than in prior periods.